Stock Price Quote

MARKSANS PHARMA LTD.

NSE : MARKSANSBSE : 524404ISIN CODE : INE750C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE82.451.2 (+1.48 %)
PREV CLOSE ( ) 81.25
OPEN PRICE ( ) 81.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 119567
TODAY'S LOW / HIGH ( )81.45 83.50
52 WK LOW / HIGH ( )35.85 97.5
NSE82.401.1 (+1.35 %)
PREV CLOSE( ) 81.30
OPEN PRICE ( ) 81.90
BID PRICE (QTY) 82.40 (20594)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1597768
TODAY'S LOW / HIGH( ) 81.50 83.55
52 WK LOW / HIGH ( )35.8 97.6
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
Mark Saldanha - Chairman Mark Saldanha - Managing Director
Registered Office

Address 11th Floor, " Grandeur ",Opp. Gundeecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W),
Mumbai,
Maharashtra-400053

Phone 022- 40012000

Email companysecretary@marksanspharma.com

Website www.marksanspharma.com

Registrars Details
Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

24Jul Marksans Pharma informs about disclosure
Pursuant to SEBI Circular No. SEBI/HO/ISD/CIR/P/2020/135 dated July 23,..
23Jul Marksans Pharma informs about board me
Marksans Pharma has informed that Board of Directors at its meeting held..
10Jul Marksans Pharma informs about media re
Marksans Pharma has informed about media release.The above information i..
10Jun Marksans Pharma informs about board me
Marksans Pharma has informed that the meeting of the Board of Directors..
10Jun Board Meeting Intimation for Notice O
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Di..

Financials

in Millions
QTR Mar 21 ANNUAL 21
Net Profit236.88983.81
Gross Profit 324.04 1243.3
Operating Profit 386.871448.68
Net Sales 1375.835995.48

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  18190.40 (1.68%)
M.Cap ( in Cr)38653.33
Gland Pharma (BSE)
peergroup  3999.45 (2.26%)
M.Cap ( in Cr)65685.84
Ajanta Pharma (BSE)
peergroup  2394.15 (2.85%)
M.Cap ( in Cr)20717.00
Hester Biosciences (BSE)
peergroup  2380.50 (2.18%)
M.Cap ( in Cr)2025.06
Strides Pharma Scien (BSE)
peergroup  774.50 (4.81%)
M.Cap ( in Cr)6948.59

Shareholding Pattern

PROMOTERS 48.25%
NON-INSTITUTION 48.05%
FII 0.59%
MUTUAL FUNDS/UTI 0.34%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%

Mf Holdings

About Marksans Pharma Ltd.

Marksans Pharma Ltd. was incorporated in the year 1992. Its today's share price is 82.45. Its current market capitalisation stands at Rs 3374.79 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4334.15 Cr and Total Income of Rs.4335.88 Cr. The company's management includes Harshavardhan Panigrahi, Abhinna Sundar Mohanty, Digant Mahesh Parikh, Seetharama Raju Buddharaju, Varddhman Vikramaditya Jain, Sandra Saldanha, Mark Saldanha, Mark Saldanha.

It is listed on the BSE with a BSE Code of 524404 , NSE with an NSE Symbol of MARKSANS and ISIN of INE750C01026. It's Registered office is at 11th Floor, " Grandeur ",Opp. Gundeecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W)Mumbai-400053, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Bhuta Shah & Co LLP, NK Mittal & Associates, VS Lalpuria & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)